Mutation of surface cysteine 374 to alanine in monoamine oxidase A alters substrate turnover and inactivation by cyclopropylamines

Ana Paula B. Vintém, Nigel T. Price, Richard B. Silverman, Rona R. Ramsay*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

48 Scopus citations

Abstract

Modification of cysteine (Cys) residues inactivates monoamine oxidases (MAO) yet the crystal structure shows no conserved cysteines in the active site of MAO A (Ma, J. et al. J. Mol. Biol. 2004, 338, 103-114). MAO A cysteine 374 was mutated to alanine and the purified enzyme characterized kinetically. The mutant was active but had decreased kcat/Km values compared to the wild-type enzyme. Cyclopropylamine-containing mechanism-based inactivators similarly showed lower turnover rates. Spectral studies and measurement of free thiols established that 1-phenylcyclopropylamine (1-PCPA) formed an irreversible flavin adduct whereas 2-phenylcyclopropylamine (2-PCPA) and N-cyclo-α-methylbenzylamine (N-CαMBA) formed adducts that allowed reoxidation of the flavin on denaturation and decreased cysteine in both wild-type and mutant MAO A. In the 1-PCPA and N-CαMBA inactivations, the partition ratio was decreased by more than 50% in the mutant. The data suggest that mutation of Cys374 influences MAO A catalysis, which has implications for MAO susceptibility to redox damage. These results are compared with previous work on the equivalent residue in MAO B, namely, cysteine 365.

Original languageEnglish (US)
Pages (from-to)3487-3495
Number of pages9
JournalBioorganic and Medicinal Chemistry
Volume13
Issue number10
DOIs
StatePublished - May 15 2005

Funding

This work was supported by the Scottish Executive Environment and Rural Affairs Department (to N.T.P.), by the National Institutes of Health (GM32634 to R.B.S.), and by AstraZeneca UK Ltd (to R.R.R.). A.P.B.V. thanks the Fundação para a Ciência e Tecnologia for her PhD studentship and the William Ramsay Henderson Trust for travel support. The technical assistance of Mrs Joan Riddell is gratefully acknowledged. We thank Dr. P. Urban, CNRS, France for the initial gift of the cDNA for MAO.

Keywords

  • Allosteric effect
  • Chemical mechanism
  • Cyclopropylamine
  • Cysteine modification
  • Monoamine oxidase

ASJC Scopus subject areas

  • Drug Discovery
  • Molecular Medicine
  • Molecular Biology
  • Biochemistry
  • Clinical Biochemistry
  • Pharmaceutical Science
  • Organic Chemistry

Fingerprint

Dive into the research topics of 'Mutation of surface cysteine 374 to alanine in monoamine oxidase A alters substrate turnover and inactivation by cyclopropylamines'. Together they form a unique fingerprint.

Cite this